Breast Cancer Services For Medical Specialties
-
Manufactured by MiraDxbased in USA
Independent of their BRCA1/BRCA2 mutational status, ...
-
based in USA
LiquidHALLMARK® is an ultrasensitive next-generation sequencing assay for genomic profiling of a patient’s unique cancer. By requiring only a single blood sample, LiquidHALLMARK provides important information for cancer care especially when tissue by invasive biopsy is insufficient or ...
-
based in USA
Mammograms are x-ray exams of the breast. They are most often used to screen for breast cancer in women who have no symptoms. Mammograms and other breast imaging tests can also be used in women who have breast symptoms, such as a lump or pain, or who have a suspicious change seen on a screening mammogram. Mammography is the only screening tool that has been demonstrated through large randomized ...
-
based in USA
Indication: Breast Cancer. Improved detection and differentiation on routine breast ultrasound, enabling faster, more accurate, and cheaper detection and treatment of breast cancer. ISSUED ...
-
Manufactured by BriaCell Therapeutics Corp.based in CANADA
Phase I/IIa Combination Study of Bria-IMT™ with retifanlimab (INCMGA00012) and epacadostat in Advanced Breast Cancer. FDA has approved the combination study of Bria-IMT™ with Incyte Corporation’s drugs, retifanlimab and epacadostat. The combination study is listed in ClinicalTrials.gov as NCT03328026. Patients With advanced breast cancer will be eligible for combination therapy ...
-
Manufactured by Targazyme, Inc.based in USA
TILs are part of the body’s natural response to cancer:The cells of the immune system perform immunosurveillance while circulating throughout the bodyAs part of the normal immune response, TIL migrate to the tumor site through recognition of chemokines produced by the tumor. TIL recognize tumors through tumor-specific antigens (TSAs) and can cause lysis to tumor cellsSolid tumors are ...
-
based in USA
Medicare risk adjustment is a process that Medicare uses to pay health plans. Medicare pays health plans based on the number of Medicare beneficiaries enrolled in the plan, and the risk scores of those beneficiaries. Medicare risk scores are calculated using a formula that takes into account many different factors, including age, sex, race, health status, and use of Medicare services. Medicare ...
-
Manufactured by BioMark Diagnostics Inc.based in CANADA
Liquid Biopsy Metabolic Panels Being Developed for Other Cancers; Glioblastoma (GBM), Breast Cancer, Head & Neck ...
-
Manufactured by Alfa Chemistrybased in USA
Methotrexate, one of the earliest cancer chemotherapy agents, which is extensively used in the treatment of cancer, including breast cancer, leukemia, lung cancer, lymphoma, osteosarcoma and so on. The efficacy of methotrexate mainly due to its inhibitory effect on dihydrofolate reductase (DHFR)[1]. DHFR catalyzes the conversion of dihydrofolate to the active tetrahydrofolate that is needed for ...
-
based in USA
Histology, tissue staining using the latest in automated staining platforms, and digital pathology services form the foundation of a strong anatomic pathology program. Anatomic Pathology at NeoGenomics offers in-house comprehensive diagnostic services, backed by highly trained professionals, to provide oncologists and pathologists the information they need to determine the best treatment strategy ...
-
Manufactured by Soteria Medical BVbased in NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...
-
based in CHINA
Cancer is a complicated disease caused by genetic variation. The genetic variation may deprive cells of the normal control function, leading to immortalization and cancer. And targeted drugs work well in cancer therapy, which can kill cancer cells that carry specific genes of variation. However, patients may differ from each other regarding the in vivo genetic variation. As a result, patients ...
-
based in USA
The deep learning AI model provides fast and powerful image analysis assistance to pathologists in their diagnostic tasks. CE-IVD marked Aiforia Clinical AI Models for Breast Cancer: Ki67, ER, and PR available now. CE-IVD marked Aiforia Clinical AI Model for Lung Cancer: PD-L1 available now. CE-IVD marked Aiforia Clinical AI Model for Prostate Cancer: Gleason Grade Groups available now. Improves ...
-
based in USA
5 year survival for breast cancer is 5x higher in the earliest stage of the ...
-
based in USA
AmpliMark is the foundational technology behind Lucence’s liquid biopsy tests. AmpliMark uses unique molecular barcodes in this error-correction technology. It is designed to improve detection of multiple mutation types like single nucleotide variants, insertions and deletions (indels), copy number variations (CNVs), fusions and microsatellite instability ...
-
Manufactured by Ascendia Pharmaceuticalsbased in USA
Biological formulation development involves discovering solutions for the most bioactive, native protein delivery. It poses a myriad of challenges due to the fact biologics consist of generally large, complex molecules that complicate drug development. Biologics are at the forefront of many current medical advances. They have established a key position in the pharmaceutical market by ...
-
based in UNITED KINGDOM
We have considerable experience in providing noise and acoustic advice for healthcare facilities. We provide cost effective advice to address the requirements of Health Technical Memorandum 08-01 (HTM 08-01) and ...
-
based in CANADA
While tissue samples are the standard for cancer molecular profiling, tissue can often be challenging to obtain. Surgical biopsy may be risky or impossible, the biopsy procedure may have resulted in insufficient or exhausted tissue, or the sample acquired resulted in poor quality DNA. Whatever the reason, plasma assays can provide a less invasive alternative or complement to tissue assays. Plasma ...
-
based in CANADA
Find It focuses on gene mutations that can be addressed by current FDA-approved therapies. Find It is more than an assay: it’s a complete solution. Canexia Health partners leverage our expert end-to-end support and proprietary technology as well as a focused panel that identifies therapeutic targets for patients, acquired drug resistance mutations, and mutations with prognostic and ...
-
Manufactured by Celemics, Inc.based in SOUTH KOREA
Customized Targeted Sequencing. BRCA1,2 (Breast Cancer). OncoRisk. CancerScreen / CancerMaster. G-Mendeliome Clinical Exome Sequnecing. G-Mendeliome Disease Specific. Customized RNA Sequencing. Customized Methy;ation Sequencing. ctDNA (Colorectal, Lung, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you